IanFVA BRAND OF IONAFAIan Financial VisionAI-Driven. Independent. For Everyone.

Latest Valuation Analysis

Institutional Intelligence & Systematic Analysis

REZI Valuation Report 2026-08-13

Resideo Technologies is a residential building technologies company focused on comfort, security, and energy management solutions through brands like Honeywell Home and ADI Global Distribution. Q2 2026 revenue reached $1.98 billion, a 2% year-over-year increase with improving profitability, driven by a 4% growth in Products & Solutions offsetting modest ADI growth. Record gross margins of 30.0% contributed to a $97 million net income, reversing a prior year loss. A key development is the completed spin-off of ADI, establishing Resideo as a pure-play building technologies firm intended to unlock value and improve capital allocation, accompanied by a $900 million debt reduction. Recent institutional activity includes moderate share sales by Gabelli Funds, and Shane Harrison is the new CFO. While earnings consistently exceed estimates, sustained performance depends on innovation and navigating macroeconomic headwinds. The company’s strategic evolution over the past four quarters demonstrates a shift towards focused growth, operational efficiency, and shareholder value creation, with a dynamic approach to capital allocation and organizational structure. Risks include increased leverage, supply chain vulnerabilities, and regulatory scrutiny, but improved capital structure and a focus on core product development position Resideo for future success.

COHR Valuation Report 2026-08-13

Coherent, Inc. manufactures laser-based technologies, serving diverse markets through component sales and integrated solutions. Recent financial results show strong growth – a 34% revenue increase in Q4 2026 (42% pro forma), with earnings per share rising to $1.74 – driven by organic growth and the II-VI Incorporated integration. While performance is positive, a disconnect exists between profitability and operational cash flow, requiring monitoring. The company benefits from demand for AI infrastructure, particularly optical components for data centers, fueling significant stock appreciation (260% in 12 months, 380% in 5 years). However, this high valuation necessitates caution given recent market corrections. Strategic shifts include portfolio optimization through divestitures and a focus on operational efficiency. Key risks include power infrastructure limitations impacting AI build-out, competition from Lumentum, and integration complexities post-acquisition. Macroeconomic factors like inflation and potential unemployment increases present challenges, while stable interest rates offer some benefit. Successful execution hinges on cost management, diversification, and translating revenue growth into sustainable cash flow.

ATEX Valuation Report 2026-08-12

Anterix Inc. owns valuable 900 MHz spectrum, leasing it for private broadband networks to utilities, critical infrastructure, and increasingly, satellite ventures. While revenue grew 38.1% in Q1 2027, profitability remains constrained by high costs associated with preparing the spectrum and navigating regulations, resulting in a $0.53 per share loss. The core investment thesis centers on the superior propagation characteristics of its low-band spectrum – crucial for reliable connectivity in challenging environments – differentiating it from higher frequency bands. The company is strategically clearing and deploying this spectrum, anticipating escalating recurring revenue as licenses are activated, supported by a strong $116 million cash position. Recent institutional activity shows mixed sentiment. While Dimensional Fund Advisors increased holdings, Gabelli Funds modestly reduced theirs. An expanded stock plan aims to incentivize personnel but introduces potential dilution. Macroeconomic factors like GDP growth, inflation, and interest rates impact both demand and operational costs. The company’s shift towards service offerings – private networks & edge computing – is projected to expand EBITDA margins and drive a CAGR of 8-12% over five years. However, the balance sheet shows cyclical volatility in net margin, free cash flow, and ROI, indicating execution risks despite positive trends. Valuation suggests moderate volatility with potential for appreciation, but requires careful monitoring of fundamentals and macroeconomic conditions.

ATRO Valuation Report 2026-08-12

Astronics Corporation is a diversified aerospace, defense, and electronics supplier experiencing accelerated growth, with Q2 2026 sales up 27% and record operating income. Revenue is split between Aerospace (larger, recurring revenue via aircraft integration) and Test Systems (cyclical, defense-focused). The company benefits from aerospace & defense tailwinds and is projected to exceed $1 billion in annual revenue. Recent performance is driven by aerospace demand, efficiency improvements, and strategic pricing. Intellectual property defense (successful UK ruling) and increased institutional investment (Assenagon) signal positive momentum. While valuation requires peer comparison, the company’s strategic focus, operational improvements, and robust backlog position it favorably. Macroeconomic factors – stable GDP, resilient defense spending – support continued growth despite potential inflation, which Astronics aims to mitigate through pricing and efficiency. Over the past year, Astronics shifted from defensive strategies to aggressive capital allocation, prioritizing growth, efficiency, and technological development. Risks include legal battles, supply chain vulnerabilities, and customer concentration, necessitating careful monitoring of WACC and working capital. Ultimately, Astronics demonstrates a trajectory of increasing revenue, margin expansion, and a commitment to long-term value creation.

ARMK Valuation Report 2026-08-12

Aramark is a diversified service provider specializing in food, facility, and uniform services, operating across education, healthcare, business, and leisure sectors. Recent financial performance shows robust revenue growth (9% to $5 billion in Q3 2026) with projected full-year organic revenue growth of 9-10% and EPS growth of 20-25%. Strategic initiatives include expansion into high-growth areas like hyperscale AI data centers (Aramark Nexus) and sustainability efforts. Investor sentiment is mixed, with some firms increasing positions while others reduce holdings, potentially due to valuation concerns and cost pressures. Despite legal challenges regarding correctional services contracts, Aramark’s diversified revenue stream mitigates risk. The company is navigating a complex macroeconomic landscape with modest GDP growth and stable inflation, focusing on cost management and efficient working capital. Management has shifted towards aggressive operational efficiency, debt restructuring, and capital allocation. Risk factors include supply chain fragility, regulatory scrutiny, and labor disputes. While maintaining a strong competitive position, Aramark’s growth relies on strategic execution, cost control, and mitigating operational risks to sustain profitability and deliver shareholder value. Valuation models suggest moderate dispersion with a target price around $61-69 over the next two years.

HRB Valuation Report 2026-08-12

H&R Block is a multi-channel tax preparation provider experiencing moderate growth, with recent revenue up 4.9% and EPS nearing 14%. This performance is driven by client retention, complex tax situations demanding professional assistance, and investments in AI to improve efficiency. While returning capital to shareholders via dividends (up 10%) and $714M in share repurchases, the business remains highly seasonal with earnings concentrated around tax season. Institutional holdings are mixed, reflecting investor uncertainty. Valuation is conservative, potentially due to fintech disruption concerns. The company navigates a challenging macroeconomic environment – potential GDP growth offset by rising unemployment and inflation – requiring strategic pricing and continued tech investment. Sustained growth depends on maintaining market share in a competitive landscape and expanding higher-margin services. Recent capital allocation demonstrates a shift towards direct revenue from franchise acquisitions, alongside consistent operational improvements. Risk factors include accuracy guarantees, cybersecurity threats, and regulatory changes. While current performance is positive, long-term double-digit EPS growth may be difficult to achieve given seasonality and competition. The company’s financial health appears stable with moderate working capital intensity, but requires disciplined investment in technology and marketing for future success.

SLAB Valuation Report 2026-08-12

Silicon Laboratories (SLAB) designs mixed-signal circuits for the Industrial and Commercial Internet of Things, generating revenue through unit sales of wireless microcontrollers and system-on-chip solutions, distributed via direct sales and representatives. Recent Q2 2026 revenue reached $228 million with EPS of $0.71, exceeding expectations, though historical growth rates aren’t specified. Product development focuses on low-power wireless connectivity, exemplified by the BG2B Bluetooth LE SoC, prioritizing power efficiency, security, and reduced system complexity. Institutional ownership provides stability, but a slight reduction in Dimensional Fund Advisors’ holdings warrants monitoring. Financially, SLAB demonstrates improving gross margins but faces competitive pressures and relies on efficient cost management. The company is undergoing a strategic shift, initially prioritizing R&D and acquisitions, then adapting to a merger with Texas Instruments, and recently refocusing on organic growth. Risk factors include supply chain concentration, regulatory hurdles related to the merger, and evolving cybersecurity threats. While macroeconomic conditions present challenges (inflation, potential unemployment increases), SLAB’s focus on energy-efficient IoT solutions positions it for growth. The company’s capital structure is shifting towards a full exit via the merger, returning cash to shareholders. Valuation suggests a potential near-term correction followed by moderate recovery, with long-term targets indicating modest appreciation contingent on sustained innovation and operational efficiency.

MIDD Valuation Report 2026-08-12

Middleby Corporation is strategically restructuring towards a focused commercial foodservice equipment business, divesting its food processing and residential kitchen segments to unlock value and streamline operations. This shift aims to capitalize on industry trends like automation and data-driven solutions, targeting higher margins through recurring revenue from aftermarket services. Recent financial performance shows modest Q2 2026 EPS beats, but the separation of the food processing division may cause short-term dilution. While Dimensional Fund Advisors’ stake reduction warrants monitoring, the market initially approved the strategic direction. The company faces macroeconomic headwinds – modest GDP growth offset by potential consumer spending reductions and inflationary pressures – requiring effective cost management and pricing power. Financial analysis reveals a decreasing debt load, but fluctuating net margins and a need for improved working capital efficiency. Long-term success hinges on integrating acquired technologies, driving organic growth within the commercial foodservice segment, and navigating a competitive landscape. Valuation is sensitive to revenue, margins, and capital allocation, with a projected long-term earnings growth rate in the high-single to low-double digits, contingent on successful execution of its focused strategy.

LITE Valuation Report 2026-08-12

Lumentum Holdings Inc. is capitalizing on increasing demand for optical and photonic products driven by AI, cloud computing, and data center expansion, evidenced by a 109% revenue increase to $1.01 billion in Q4 2026 and a 50.4% adjusted gross margin. The company is strategically focused on high-bandwidth data transmission, investing in technologies like Super Transport Blades and VCSELs, and has seen eight consecutive quarters of growth. Despite positive financial performance and projected revenue of $1.23-$1.27 billion for Q1 2027, market reaction has been muted, potentially due to valuation concerns. While facing competition from companies like Coherent, Lumentum’s established market position and innovation provide a degree of defensibility. Key considerations include managing working capital, potential dilutive financing, and supply chain dynamics, particularly regarding EML availability. Macroeconomic factors, including modest GDP growth, stable interest rates, and contained inflation, support continued investment in technology infrastructure. Lumentum’s recent restructuring prioritizes capital allocation for growth within optical networks and data centers, streamlining operations and focusing on innovation. The company’s risk profile includes supply chain vulnerabilities, customer concentration, and regulatory compliance, but proactive risk management and a focus on ‘second curve’ growth engines—like automotive LiDAR—position it for sustained long-term value creation.

CAH Valuation Report 2026-08-12

Cardinal Health operates as a diversified healthcare services and products company, primarily a pharmaceutical and medical device supply chain intermediary, generating revenue through distribution and value-added services. Recent fiscal results show 6% revenue growth to $63.7 billion, with a substantial 70% increase in GAAP diluted EPS to $1.70, boosted by one-time tariff refunds. Non-GAAP EPS grew 25% to $2.60, and management projects 13-15% growth for fiscal year 2027, driven by the specialty pharmaceutical segment. The company prioritizes shareholder returns with $1.4 billion in share repurchases and a consistent dividend. Valuation indicates a moderate premium based on EBITDA multiples, reflecting its scale. Sustainability of earnings hinges on navigating generic drug pricing pressures and maintaining specialty segment growth. Macroeconomic factors, including modest GDP growth and inflationary pressures, present both challenges and opportunities. Cardinal Health is strategically shifting towards acquisitions in areas like Management Service Organizations and at-home solutions, emphasizing operational efficiency and integrated care. While facing risks from regulatory changes and litigation, the company demonstrates improving operational resilience and margin expansion, with a focus on long-term value creation.